Skip to main content
Figure 3 | Critical Care

Figure 3

From: Impact of transpulmonary thermodilution-based cardiac contractility and extravascular lung water measurements on clinical outcome of patients with Takotsubo cardiomyopathy after subarachnoid hemorrhage: a retrospective observational study

Figure 3

Changes in cardiac function index during volume expansion and hyperdynamic therapy for delayed cerebral ischemia–related neurological deterioration in 25 subarachnoid hemorrhage patients with Takotsubo cardiomyopathy. Graph shows changes in cardiac index (CI), global end-diastolic volume index (GEDI) and cardiac function index (CFI) during volume expansion with 500 ml of 6% hydroxyethyl starch (HES) (n = 112) or hyperdynamic therapy with dobutamine (DOB) (n = 55). Data were collected before and after each challenge (a 500 ml infusion of HES or an incremental infusion (3 μg/kg/min) of DOB, sampled in situations without coadministration) between days 4 and 14. *P < 0.05, **P < 0.01 compared with baseline before each challenge (% change).

Back to article page

Critical Care

ISSN: 1364-8535